Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (ACRV)

Q: What does CUSIP 004890109 represent in this 13F holders report?

CUSIP 004890109 is the security identifier for ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") used to aggregate holder disclosures.

Q: How many institutions held ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") in Q2 2026?

3 institutional investors reported ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") for Q2 2026. Use the holders table for investor-level position and value details.

CUSIP: 004890109

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, par value $0.001 per share (the "Shares")
Total 13F shares: 11,797
Total 13F value: $20,999
Share change: +1,045
SEC-reported price per share: $1.78
Number of holders: 3
Value change: +$1,860
Number of buys: 2
Shares outstanding: 42,655,924

Security key

004890109

Report period

Q2 2026

Institutions

Top holders

ACRV full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 Acrivon Therapeutics, Inc. SEC filings Acrivon Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 004890109

Previous quarter: Q1 2026

Recent filing periods:

Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Ownership snapshot

Top reported holders of ACRV - Acrivon Therapeutics, Inc. - Common Stock, par value $0.001 per share (the "Shares") (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

RA CAPITAL MANAGEMENT, L.P.

Disclosed value leader

RA CAPITAL MANAGEMENT, L.P.

Comparable rows

15/15

Latest evidence

21 May 2026

13D/G 3/4/5 13F Lead comparable stake: 29% 13D/G row: RA CAPITAL MANAGEMENT, L.P. Showing 1-6 of 15 holder rows.

Quick read

RA CAPITAL MANAGEMENT, L.P. leads the comparable SEC ownership view at 29%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens RA CAPITAL MANAGEMENT, L.P.'s linked filing trail.

Comparable ownership Top 5

RA CAPITAL MANAGEMENT, L.P. 29%

Sands Capital Life Sciences Pulse... 6.8%

PERCEPTIVE ADVISORS LLC 7.3%

Kristina Masson 6.2%

Sands Capital Alternatives, LLC 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
RA CAPITAL MANAGEMENT, L.P.	13D/G 3/4/5 13F Director, 10%+ Owner · Company 13D/G 3/4/5 13F	29%	$15,847,529 12,284,906 shares	+$5,016,666	22 Apr 2026
Sands Capital Life Sciences Pulse Fund II, L.P.	13D/G 13D/G	6.8%	$2,525,900 2,122,605 shares	$0	30 Jun 2025
PERCEPTIVE ADVISORS LLC	3/4/5 10%+ Owner 3/4/5	7.3%	$4,159,546 3,104,139 shares	—	30 Apr 2025
Kristina Masson	3/4/5 EVP - Business Operations, Director 3/4/5	6.2%	$3,658,006 2,631,660 shares	—	21 May 2026
Sands Capital Alternatives, LLC	13F Company 13F	5%	$2,950,421 2,122,605 shares	—	31 Mar 2026
WELLINGTON MANAGEMENT GROUP LLP	13F Company 13F	2.1%	$1,234,501 888,130 shares	—	31 Mar 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

11,797

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders

Q2 2026 holders

Holder diff

-40

Investor	Q1 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q1 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend